Tuesday, November 29, 2022

Pharma News

Health Europa brings you the latest Pharma News the field of European Healthcare & Social Care Policy.

UCL researchers' trial anti-sickness drug for dementia hallucinations

UCL researchers’ trial anti-sickness drug for dementia hallucinations

Ondansetron, an anti-sickness drug used in the NHS for cancer patients could treat hallucinations in dementia patients. University College London is trialling an anti-sickness drug...
New anti-cancer drug in development

New anti-cancer drug in development  

Researchers in the US have been working on a new anti-cancer drug. The drug will be absorbed through the gut’s lymphatic system, allowing new...
New mRNA cancer vaccine eliminates tumours

New mRNA cancer vaccine eliminates tumours

A new mRNA-based cancer vaccine shows potential in eliminating tumours and preventing recurrence in mice. Cancer vaccines are a controversial topic with plenty of research...
New method reduces pain after knee replacement surgery

New method reduces pain after knee replacement surgery

A new study finds that infusing morphine into shin bone could reduce pain after knee replacement surgery. A recent study by Houston Methodist researchers found...
Prostate drug could revolutionise motor neuron disease treatment

Prostate drug could revolutionise motor neuron disease treatment

A new study has found a repurposed drug could help patients with their motor neuron disease treatment. University of Edinburgh researchers have found a drug...
The equation symbolising the mathematical model of osteoporosis overlaid on an image showing osteoporotic fractures (red) in the thoracic spine.

Predicting effective drug combinations for postmenopausal osteoporosis

A new mathematical model could help clinicians choose effective combinations of medications for postmenopausal osteoporosis. Postmenopausal osteoporosis occurs when the sudden loss of oestrogen during...
Azenta announces acquisition of B Medical Systems

Azenta announces acquisition of B Medical Systems

Azenta Inc. has announced its agreement to acquire B Medical Systems, a market leader in temperature-controlled storage and transportation solutions. In an exciting development, Azenta...
Defence's successful study on the ACCUVAC-PT007 vaccine

Defence Therapeutics receives US patent for its ADC Platform Technology

In an exciting development, Defence Therapeutics has received a US patent covering its ADC Platform Technology. In the latest announcement on August 8th, 2022, Defence...
New lung cancer treatment stops cancer from worsening for over two years 

Lung cancer treatment stops cancer worsening for over two years 

A life-extending lung cancer treatment is available on the NHS, which could benefit over 550 patients a year. The revolutionary lung cancer treatment is called...
WHO recommends cabotegravir for HIV prevention

WHO recommends cabotegravir for HIV prevention

New WHO guidelines recommend countries implement cabotegravir into their HIV prevention strategy. The World Health Organization (WHO) has released new guidelines for cabotegravir (CAB-LA) and...
NHS saves £1.2 billion of taxpayer money on cutting-edge medications

NHS saves £1.2 billion of taxpayer money on cutting-edge medications

In a new press release, the NHS has stated they have saved £1.2bn on life-changing medications by securing cost-effective deals. The NHS has announced that...
Scientists develop innovative non-opioid pain killer

Scientists develop innovative non-opioid pain killer

Scientists from the University of Warwick have developed a non-opioid pain killer with minimal side effects. Opioids are a class of drugs that work to...
WHO: Alarming data shows childhood vaccinations are declining

WHO: Alarming data shows childhood vaccinations are declining

Official data from WHO and UNICEF finds the largest sustained decline in childhood vaccinations in around 30 years. In the UK, children up to 15...
insulin therapy

S100A9 protein may provide an alternative to insulin therapy

University of Geneva (UNIGE) scientists have demonstrated that the S100A9 protein can be developed into an effective diabetes treatment and could one day replace...
NICE recommends two new affordable breast cancer treatments

NICE recommends two new affordable breast cancer treatments

NICE has agreed to an affordable deal for two breast cancer treatments, available immediately to patients on the NHS. In the final draft guidance, NICE...
NICE approves first new mesothelioma cancer treatment in 15 years

NICE approves first new mesothelioma cancer treatment in 15 years

Exciting news arrives from the NHS as they announce the first treatment for mesothelioma cancer in over a decade is now approved. This new treatment...
Implementing an antibiotic subscription model into the UK healthcare system

Extending the UK’s leadership with an antibiotic subscription model to tackle AMR

Following the UK’s top ranking in the recent AMR Preparedness Index, Michael Hodin and Peter Jackson discuss the country’s novel antibiotic subscription model and...
alpelisib

Alpelisib becomes 100th fast tracked NHS cancer drug

Alpelisib – a life-extending drug for patients with advanced breast cancer – has become the 100th fast-tracked cancer drug on the NHS and will...
nerve damage

Experimental drug repairs nerve damage from spinal cord injury

A groundbreaking study from the University of Birmingham has shown that a candidate drug called AZD1390 can repair nerve damage following a spinal cord...
Microdosing psilocybin

Microdosing psilocybin shows effectiveness in improving mental health

Evidence from a University of British Colombia investigation suggests that microdosing psilocybin may be an effective treatment for mental health conditions. The Microdose.me project, published in...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest